Lay Hoon Goh
Datos Biográficos
| ID | 9023661 |
|---|---|
| NOMBRE | Lay Hoon Goh |
| NOMBRES | Lay Hoon |
| APELLIDO | Goh |
| FIRMA | GOH L H |
| AFILIACIONES | National University of Singapore |
| ORCID | 0000-0003-1536-3050 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2024 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2025 |
| ÍNDICE H | 0 |
Hla-B*58
Allopurinol remains the first-line treatment for gout; however, it carries a risk of severe cutaneous adverse reactions (SCARs), particularly among carriers of the HLA-B*58:01 allele. In the Asia-Pacific region, screening practices vary widely due to infrastructure gaps, cost concerns, and differing health policies. For example, while cost-effectiveness analyses have influenced screening decisions in some countries, they often overlook long-term …
Changes in reasons for visits to primary care after the start of the Covid-19 pandemic
Background The COVID-19 pandemic has reshaped healthcare delivery worldwide. Objective To explore potential changes in the reasons for visits and modality of care in primary care settings through the Int ernational Conso r tium of P rimary Care B i g D ata Researchers (INTRePID). Methods We conducted a cross-sectional, retrospective study from 2018–2021. We examined visit volume, modality, and reasons for visits to primary care in Argentina, Aust…
Sin obras prominentes en esta página.
Changes in reasons for visits to primary care after the start of the Covid-19 pandemic
Background The COVID-19 pandemic has reshaped healthcare delivery worldwide. Objective To explore potential changes in the reasons for visits and modality of care in primary care settings through the Int ernational Conso r tium of P rimary Care B i g D ata Researchers (INTRePID). Methods We conducted a cross-sectional, retrospective study from 2018–2021. We examined visit volume, modality, and reasons for visits to primary care in Argentina, Aust…
Hla-B*58
Allopurinol remains the first-line treatment for gout; however, it carries a risk of severe cutaneous adverse reactions (SCARs), particularly among carriers of the HLA-B*58:01 allele. In the Asia-Pacific region, screening practices vary widely due to infrastructure gaps, cost concerns, and differing health policies. For example, while cost-effectiveness analyses have influenced screening decisions in some countries, they often overlook long-term …
Medicine (2 obras) · Antigen (1 obras) · Autoimmune Bullous Skin Diseases (1 obras) · China (1 obras) · Confidence interval (1 obras) · COVID-19 and healthcare impacts (1 obras) · Demography (1 obras) · Disease (1 obras) · Drug-Induced Adverse Reactions (1 obras) · Family medicine (1 obras)